HealthQuill Articles by: HealthQuill
The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory at the Milner Therapeutics Institute
Drugs Health Pharma

Cambridge Univ, AstraZeneca, MRC to set up genomics laboratory

HQ Team November 29, 2023: The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory

Read More
The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization currently chaired by China for the standardization of medical devices, due to a divergence of views.
Drugs Medical Pharma

FDA pulls out of 33-member medical devices body as differences emerge

HQ Team November 28, 2023: The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization

Read More
Eli Lilly’s weight-loss injection Zepbound, taken along as a supplement with diet and exercise, got the USFDA and UK regulator’s nod after clinical trials proved adults lost 48 pounds on average during treatment.
Drugs Medical Pharma

Eli Lilly’s Zepbound outperforms Novo’s Wegovy in weight loss study

HQ team November 28, 2023: A recent comparative analysis of Eli Lilly and Novo Nordisk’s weight loss drugs on diabetes patients showed Eli

Read More
Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.
Drugs Medical Pharma

Argenx’s Vyvgart faces setback in autoimmune treatment trial

HQ Team November 28, 2023: Argenx SE, a Belgian biopharmaceutical announced that its experimental drug Vyvgart Hytrulo failed in trials in treating immune

Read More
Alembic FDA nod
Climate Health Pharma

Environment, lifestyle behind epidemic of autoimmune diseases

HQ Team November 28, 2023: An escalating global crisis is unfolding as an increasing number of individuals grapple with autoimmune diseases, conditions wherein

Read More
German biotechnology company, BioNTech SE announced a $ 90 million program in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a  vaccine for mpox.
Health Medical Pharma

WHO confirms 1st case of sexual spread of Mpox in Congo

HQ Team November 25, 2023: The first Mpox patient to contact the disease through sexual contact has been confirmed by the WHO in

Read More
A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching, according to researchers at Harvard Medical School.
Drugs Health Pharma

Bacterium S. aureus behind happiness of having to scratch for every itch

HQ Team November 24, 2023: A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching,

Read More
One in five children and young people in England aged between eight and 25 had a probable mental disorder in 2023, a report by the National Health Service, a publicly-funded healthcare system, found.
Drugs Health Pharma

1 in 5 kids, young people in England probably had a mental disorder in 2023

HQ Team November 24, 2023: One in five children and young people in England aged between eight and 25 had a probable mental

Read More
The World Health Organisation is monitoring an increase in children’s illness caused by pathogens, including acute respiratory syndrome coronavirus 2, in northern China.
Climate Health Pharma

WHO keeping an eye on a surge of respiratory illness in northern China

The World Health Organization is monitoring an increase in children’s illness caused by pathogens, including acute respiratory syndrome coronavirus 2, in northern China.

Read More
— at a time when President Emmanuel Macron is taking steps to stem the country’s industrial decline.
Drugs Health Pharma

Novo Nordisk invests $2.3b in France for diabetes, obesity drugs

HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France.

Read More